Changing winds: A wave of partnership, acquisitions and deals bring money back to biotech VCs

The long-predicted surge of merger and acquisition activity has finally struck the highly fragmented life sciences sector. This KnowledgeLine explores the consolidation mania sweeping through the biotech industry—a trend that is already transforming how life sciences companies secure the resources needed to build sustainable businesses and develop innovative medical products.